Humankind Investments LLC

Position in EXEL — Exelixis, Inc.

CIK 1845373 NEW YORK, NY

Position in EXEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,441,865

+$305,280 QoQ

Shares Held

26,500

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.97%

of 13F equity value

Holder Rank

#301

of 751 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Humankind Investments LLC holds $4,897,596 across 3 Biotechnology names. EXEL ranks #2 (29.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	17,500	$2,322,775
2	EXEL	Exelixis, Inc. This page	26,500	$1,441,865
3	BMRN	Biomarin Pharmaceutical Inc	19,800	$1,132,956

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,441,865	26,500	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,136,585	26,500	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.